TrialClinical and translational science2019

NYX-2925, A Novel N-methyl-D-aspartate Receptor Modulator: A First-in-Human, Randomized, Double-blind Study of Safety and Pharmacokinetics in Adults.

David R Houck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.